COLLEGIUM PHARMACEUTICAL, INC - 10-Q Filing
Collegium Pharmaceutical reports Q3 2026 financial results including product revenue breakdowns for Belbuca, Xtampza ER, and Jornay PM.
Tickers: $COLL
Collegium Pharmaceutical reports Q3 2026 financial results including product revenue breakdowns for Belbuca, Xtampza ER, and Jornay PM.
Tickers: $COLL